No clinical trials have tested them for ADHD treatment." (Source: Understood.org, 2026) Psychiatry News published a February 2026 journal digest on GLP-1 drugs and neurological conditions, noting the field remains "early and speculative." Several explanations are plausible, though none are specific to ADHD treatment: Reduced "food noise" : GLP-1 drugs quiet intrusive thoughts about food and eating
The central actions of GLP-1 underline its role in the integrated control of metabolism and behaviour, as well as a treatment strategy for disorders of maladaptive reward behaviours (chronic hyperphagia and substance abuse)
Kimura, H
Rodriguez, conducted a cohort study involving 125,474 patients who started GLP-1 medications, including Victoza (liraglutide), Ozempic and Wegovy, and Mounjaro and Zepbound between January 1, 2018 and December 31, 2023
This medicines product information is available in all official EU languages
The Committee is further dedicated to animal welfare on a Emphasize the conduct global scale by the signing of the Marseille of only necessary and Declaration on the worldwide implementation scientifically sound animal of high standards for animals housed and used studies internally and externally by the industry for scientific purposes in 2024 and the continuous collaboration with the other signatories in With the aim of increasing company-wide Impact matters concerning animal welfare
